Abstract
Electrical stimulation of the carotid baroreflex has been thoroughly investigated
for treating drug-resistant hypertension in humans. However, a previous study from
our laboratory, performed in conscious rats, has demonstrated that electrical stimulation
of the carotid sinus/nerve (CS) activated both the carotid baroreflex as well as the
carotid chemoreflex, resulting in hypotension. Additionally, we also demonstrated
that the carotid chemoreceptor deactivation potentiated this hypotensive response.
Therefore, to further investigate this carotid baroreflex/chemoreflex interaction,
besides the hemodynamic responses, we evaluated the respiratory responses to the electrical
stimulation of the CS in both intact (CONT) and carotid chemoreceptors deactivated
(CHEMO-X) conscious rats. CONT rats showed increased ventilation in response to electrical
stimulation of the CS as measured by the respiratory frequency (fR), tidal volume
(VT) and minute ventilation (VE), suggesting a carotid chemoreflex activation. The carotid chemoreceptor deactivation
abolished all respiratory responses to the electrical stimulation of the CS. Regarding
the hemodynamic responses, the electrical stimulation of the CS caused hypotensive
responses in CONT rats, which were potentiated by the carotid chemoreceptors deactivation.
Heart rate (HR) responses did not differ between groups. In conclusion, the present
study showed that the electrical stimulation of the CS, in conscious rats, activates
both the carotid baroreflex and the carotid chemoreflex driving an increase in ventilation
and a decrease in AP. These findings further contribute to our understanding of the
electrical stimulation of CS.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Autonomic Neuroscience: Basic and ClinicalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.Hypertension. 2015; 65: 1217-1222
- Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats.Auton. Neurosci. 2002; 97: 110-115
- Control of breathing in experimental anemia.Respir. Physiol. 1970; 10: 384-395
- Heart disease and stroke statistics—2018 update: a report from the American Heart Association.Circulation. 2018; 137: e67-e492
- Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.J. Am. Coll. Cardiol. 2011; 58: 765-773
- Drug adherence in hypertension.Pharmacol. Res. 2017; 125: 142-149
- Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.Circulation. 2008; 117: e510-e526
- Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.JAMA. 2013; 310: 959
- Sustained reduction of blood pressure with baroreceptor activation therapy: results of the 6-year open follow-up.Hypertension. 2017; 69: 836-843
- Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.Curr. Hypertens. Rep. 2012; 14: 238-246
- The importance of timing on the respiratory effects of intermittent carotid sinus nerve stimulation.J. Physiol. 1972; 222: 297-318
- Cardiovascular responses of conscious rats to carotid body chemoreceptor stimulation by intravenous KCN.J. Auton. Nerv. Syst. 1993; 42: 63-69
- Alterations in the cardiovascular control by the chemoreflex and the baroreflex in old rats.Am. J. Phys. 1996; 270: R310-R313
- Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia.Auton. Neurosci. 2013; 174: 8-14
- Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.Hypertension. 2010; 55: 619-626
- An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.J. Vasc. Surg. 2006; 44: 1213-1219
- Electrical carotid sinus stimulation in treatment resistant arterial hypertension.Auton. Neurosci. 2012; 172: 31-36
- Carotid baroreceptor stimulation blood pressure response mapped in patients undergoing carotid endarterectomy (C-Map study).Auton. Neurosci. 2016; 201: 60-67
- Role of chemoreceptor activation in hemodynamic responses to electrical stimulation of the carotid sinus in conscious rats.Hypertension. 2015; 66: 598-603
- Hypoxia inhibits baroreflex vagal bradycardia via a central action in anaesthetized rats.Exp. Physiol. 1999; 84: 47-56
- Effect of carotid sinus nerve stimulation on cardiorespiratory responses pattern.Am. J. Phys. 1976; 230: 951-958
- Prolonged activation of the baroreflex produces sustained hypotension.Hypertension. 2004; 43: 306-311
- Prolonged activation of the baroreflex abolishes obesity-induced hypertension.Hypertension. 2007; 49: 1307-1314
- Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H402-H409
- Ventilation measured by body plethysmography in hibernating mammals and in poikilotherms.Respir. Physiol. 1973; 17: 32-44
- Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure.J. Physiol. 2014; 592: 391-408
- Morphology of the rat carotid sinus nerve. I. Course, connections, dimensions and ultrastructure.J. Neurocytol. 1983; 12: 345-372
- Inhibition of baroreflex vagal bradycardia by selective stimulation of arterial chemoreceptors in rats.Exp. Physiol. 1999; 84: 897-906
- Variable role of carotid bodies in cardiovascular responses to exercise, hypoxia and hypercapnia in spontaneously hypertensive rats.J. Physiol. 2018; 596: 3201-3216
- The carotid sinus nerve – structure, function and clinical implications.Anat. Rec. 2018; ([Epub ahead of print])
- Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets.Diabetes. 2013; 62: 2905-2916
- Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015.J. Am. Coll. Cardiol. 2017; 70: 1-25
- Diagnosis and management of resistant hypertension.Heart. 2017; 103: 1295-1302
- Peripheral chemoreflex/arterial baroreflex interaction in patients with electrical carotid sinus stimulation (ChemoBar).(Available from:) (ClinicalTrials.gov identifier (NCT number): NCT02587533)
- An implantable carotid sinus Baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.Eur. J. Vasc. Endovasc. Surg. 2007; 33: 414-421
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2018; 138: e426-e483https://doi.org/10.1161/CIR.0000000000000597
- Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.Hypertension. 2009; 54: 530-536
- Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure.Hypertension. 2007; 50: 904-910
Article info
Publication history
Published online: December 03, 2018
Accepted:
December 1,
2018
Received in revised form:
November 30,
2018
Received:
August 17,
2018
Identification
Copyright
© 2018 Elsevier B.V. All rights reserved.